Focal Deletions of a Promoter Tether Activate the IRX3 Oncogene in T Cell Acute Lymphoblastic Leukemia
Sunniyat RahmaniD, Gianna Bloye, Nadine Farah, Jonas DemeulemeesteriD, Joana R. CostaiD, David O’ConnoriD, Rachael PocockiD, Tanya Rapoz-D’SilvaiD, Adam TurnaiD, Lingyi Wang, SooWah Lee, Adele K. FieldingiD, Juliette RoelsiD, Roman JaksikiD, Małgorzata DawidowskaiD, Pieter Van VlierbergheiD, Suzana HadjuriD, Jim R. HughesiD, James O. J. DaviesiD, Alejandro GutierreziD, Michelle A. Kelliher, Peter Van LooiD, Mark A. DawsoniD, Marc R. MansouriD
Abstract
Oncogenes can be activated in cis through multiple mechanisms including enhancer hijacking events and noncoding mutations that create enhancers or promoters de novo. These paradigms have helped parse somatic variation of noncoding cancer genomes, thereby providing a rationale to identify noncanonical mechanisms of gene activation. Here we describe a novel mechanism of oncogene activation whereby focal copy number loss of an intronic element within the FTO gene leads to aberrant expression of IRX3, an oncogene in T cell acute lymphoblastic leukemia (T-ALL). Loss of this CTCF bound element downstream to IRX3 (+224 kb) leads to enhancer hijack of an upstream developmentally active super-enhancer of the CRNDE long noncoding RNA (-644 kb). Unexpectedly, the CRNDE super-enhancer interacts with the IRX3 promoter with no transcriptional output until it is untethered from the FTO intronic site. We propose that promoter tethering of oncogenes to inert regions of the genome is a previously unappreciated biological mechanism preventing tumorigenesis.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TCF3::HLF Orchestrates an Enhancer-Promoter Network with Activation of MEF2C to Promote Immature HSC gene Expression in Leukemia
Valdemar Priebe, Bartimée Galvan, … Jean‐Pierre Bourquin·Science AdvancesPeer-reviewed·May 6, 2026
- Critical roles of Ikaros and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia
Yali Ding, Bing He, … Sinisa Dovat·LeukemiaPeer-reviewed·Jun 24, 2025
- E4F1 and ZNF148 are transcriptional activators of the A57C and wildtype TERT promoter
B. H. Chua, L. Ferry, … D. Kappei·bioRxiv·Jan 13, 2023
- NFAT are Essential and Redundant Actors for Leukemia Initiating Potential in T-cell Acute Lymphoblastic Leukemia
C. Catherinet, D. Passaro, … C. Tran Quang·bioRxiv·Oct 30, 2020
- The TARZN complex binds de novo enhancer mutations and promotes oncogenic expression in T-ALL
Nurkaiyisah Zaal Anuar, Chai Yeen Goh, … Dennis Kappei·bioRxiv·Jan 24, 2025
- Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in a Murine Model of T Acute Lymphoblastic Leukemia
T. Carr, S. McGregor, … B. L. Kee·bioRxiv·Nov 8, 2021